Success Story: 17-Day NIW Approval! Indian Lab Specialist Achieves Success with Our Expert’s Strategy and Premium Processing

Client’s Testimonial:

“Great News. I really appreciate your support and guidance throughout the I-140 NIW process.”

On March 10^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Lab Specialist Senior in the Field of Radiopharmaceutical Medicinal Chemistry (Approval Notice).

General Field: Radiopharmaceutical Medicinal Chemistry

Position at the Time of Case Filing: Lab Specialist Senior

Country of Origin: India

State of Residence at the Time of Filing: Virginia

Approval Notice Date: March 10^th, 2025

Processing Time: 17 days (Premium Processing Requested)

Case Summary:

At North America Immigration Law Group, we are proud to announce the successful approval of an I-140 National Interest Waiver (NIW) petition for an exceptional expert in radiopharmaceutical medicinal chemistry. The petition received a decision just after 17 days, with Direct Premium Processing at the time of filing. This achievement underscores the vital importance of their contributions to molecular imaging and therapeutic advancements.

The petitioner, who holds a Ph.D. in medicinal chemistry, is a leading expert dedicated to developing and optimizing radiotracer synthesis, formulations, and quality control methods for molecular imaging. This crucial research aims to enhance early diagnosis and targeted treatment strategies for neurodegenerative diseases and cancers, while also ensuring the safety and efficacy of radiotracers in clinical applications. Their proposed endeavor holds substantial merit and national importance by addressing the immense global health burden of cancer (over 20 million new cases annually) and the significant economic impact of neurodegenerative diseases in the United States (exceeding $655 billion annually). Their innovations enable earlier and more precise detection, leading to more effective personalized treatments.

The client is currently employed at a U.S. institution and plans to pursue employment as a radiopharmaceutical medicinal chemist in the U.S., where they will continue to develop novel radiopharmaceuticals for the diagnosis and treatment of various cancers and neurodegenerative diseases, and publish original research in their field.

To support the NIW petition, we presented compelling evidence of the researcher’s distinguished contributions to the field of radiopharmaceutical medicinal chemistry:

● A strong publication record, including 14 peer-reviewed journal articles, 4 patent applications, and 6 granted patents.

● An impressive citation count of 920, demonstrating that their published work is widely recognized and relied upon by peers.

● The national importance of their research is further highlighted by its direct relevance to advancing the U.S. in critical and emerging technologies like medical imaging and biotechnology.

We are honored to have supported this gifted expert and look forward to their continued groundbreaking contributions to the diagnosis and treatment of severe diseases in the United States and globally.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.